Phenotypic and genetic diversity of invasive pneumococcal isolates recovered from French children

Journal of Clinical Microbiology

Volumn 40, Issue 8, 2002, Pages 2994-2998

  Doit, Catherine ^a   Loukil, Chawki ^a   Geslin, Pierre ^a   Bingen, Edouard ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD CULTURE; CEREBROSPINAL FLUID CULTURE; CHILD; CONTROLLED STUDY; FRANCE; GENETIC VARIABILITY; HUMAN; INFANT; MENINGITIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RIBOTYPING; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; CHILD; CHILD, PRESCHOOL; FRANCE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MENINGITIS, PNEUMOCOCCAL; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PENICILLINS; PHENOTYPE; PNEUMOCOCCAL INFECTIONS; RIBOTYPING; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VARIATION (GENETICS);

ANIMALIA; BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0036701946     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.8.2994-2998.2002     Document Type: Article

References (22)

1. Adams, W. G. 1993. Decline of childhood H. influenzae type b disease in the Hib vaccine era. JAMA 269:221-226.
2. Alpern, E. R., E. A. Alessandri, K. L. McGowan, L. M. Bell, and K. N. Shaw. 2001. Serotype prevalence of occult pneumococcal bacteremia. Pediatrics 108:E23.
3. American Academy of Pediatrics Committee on Infectious Diseases. 2000. Policy statement: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine and antibiotic prophylaxis. Pediatrics 106:362-366.
4. Bingen, E., E. Denamur, N. Lambert-Zechovsky, et al. 1992. Mother-to-infant vertical transmission and cross-colonization of Streptococcus pyogenes confirmed by DNA restriction fragment length polymorphism analysis. J. Infect. Dis. 165:147-150.
5. de Benoist, A. C., V. Goulet, and E. Laurent. 1999. Infections invasives à Haemophilus influenzae, Listeria monocytogenes, méningocoque, pneumocoque, streptocoques A et B en France en 1997, p. 156-160. In Annual Epidemiological Report. Infectious Diseases Epidemiology in France in 1997. Réseau National de Santé Publique, Saint Maurice, France.
6. Doit, C., S. Bonacorsi, A. Frémaux, et al. 1994. In vitro killing activity of antibiotics at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis. Antimicrob. Agents Chemother. 38:2655-2659.
7. Doit, C., B. Picard, C. Loukil, P. Geslin, and E. Bingen. 2000. Epidemiologic survey of penicillin-susceptible and -resistant Streptococcus pneumoniae recovered from patients with meningitis in France. J. Infect. Dis. 181:1971-1978.
8. Eskola, J., T. Kilpi, A. Palmu, J. Jokinen, J. Haapakoski, E. Herva, A. Takala, H. Käythi, P. Karma, R. Kohberger, G. Siber, and H. Mäkelä. 2001. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N. Engl. J. Med. 344:403-409.
9. Hausdorff, W. P., J. Bryant, C. Kloek, P. R. Paradiso, and G. R. Siber. 2000. The contribution of specific pneumococcal serogroups to different disease manifestations: Implications for conjugate vaccine formulation and use, part II. Clin. Infect. Dis. 30:122-140.
10. Hausdorff, W. P., G. Siber, and P. R. Paradiso. 2001. Geographical difference in invasive pneumococcal disease rates and serotype frequency in young children. Lancet 357:950-952.
11. Kaltoft, M. S., N. Zeuthen, and H. B. Konradsen. 2000. Epidemiology of invasive pneumococcal infections in children aged 0-6 years in Denmark: A 19-year nationwide surveillance study. Acta Paediatr. 89(Suppl.):3-10.
12. Kim, K. S. 2001. Escherichia coli translocation at the blood-brain barrier. Infect. Immun. 69:5217-5222.
13. Klugman, K. P., and I. R. Friedland. 1995. Antibiotic-resistant pneumococci in pediatric disease. Microb. Drug Resist. 1:5-8.
14. Lebart, L., A. Morineau, and K. M. Warwick. 1984. Multivariate Descriptive Analysis: Correspondence Analysis and Related Techniques for Large Matrices. Wiley-Interscience, New York, N,Y.
15. McGee, L., J. McDougal, J. Zhou, et al. 2001. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by pneumococcal molecular epidemiology network. J. Clin. Microbiol. 39:2565-2571.
16. Nahm, M. H., J. V. Olander, and M. Magyarlaki. 1997. Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae. J. Infect. Dis. 176:698-703.
17. National Committee for Clinical Laboratory Standards. 1994. Performance Standards for Antimicrobial Susceptibility Testing. Fifth Informational Supplement M100-S5. NCCLS publication M100-S6. National Committee for Clinical Laboratory Standards, Villanova, Pa.
18. Robinson, K. A., W. Baughman, G. Rothrock, et al. 2001. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998. Opportunities for prevention in the conjugate vaccine era. JAMA 285:1729-1735.
19. Soininen, A., H. Pursiainen, T. Kilpi, and H. Käyhty. 2001. Natural development of antibodies to pneumococcal capsular polysaccharides depends on the serotype: Association with pneumococcal carriage and acute otitis media in young children. J. Infect. Dis. 184:569-576.
20. Spratt, B., and B. M. Greenwood. 2000. Prevention of pneumococcal disease by vaccination: Does serotype replacement matter. Lancet 356:1210-1211.
21. Tenehaus, M., and F. W. Young. 1985. An analysis and synthesis of multiple correspondence analysis, optimal scaling, dual scaling, homogeneity analysis and other methods for quantifying categorical multivariate data. Psychometrika 50:91-119.
22. Väkeväinen, M., C. Eklund, J. Eskola, and H. Käyhty. 2001. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants. J. Infect. Dis. 184:789-793.